These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27988503)

  • 1. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
    Pyne MT; Mallory M; Hillyard DR
    J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and monitoring of HCV infection using the cobas
    Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
    J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
    Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
    J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
    Chevaliez S; Bouvier-Alias M; Rodriguez C; Soulier A; Poveda JD; Pawlotsky JM
    J Clin Microbiol; 2013 Apr; 51(4):1078-82. PubMed ID: 23325825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
    Vermehren J; Maasoumy B; Maan R; Cloherty G; Berkowski C; Feld JJ; Cornberg M; Pawlotsky JM; Zeuzem S; Manns MP; Sarrazin C; Wedemeyer H
    Clin Infect Dis; 2016 May; 62(10):1228-1234. PubMed ID: 26908802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the Roche cobas
    Tan NK; Carrington D; Pope CF
    J Med Microbiol; 2018 Dec; 67(12):1711-1717. PubMed ID: 30325300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
    Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
    Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
    Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
    Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
    Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
    Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the QIAGEN artus HCV QS-RGQ test with the Roche COBAS Ampliprep/COBAS TaqMan HCV test v2.0 for the quantification of HCV-RNA in plasma samples.
    Schønning K
    J Clin Virol; 2014 Aug; 60(4):323-7. PubMed ID: 24894603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.
    Butcher A; Aslam S; Hemyari P; Cowen U; Heilek G
    J Clin Virol; 2014 Aug; 60(4):336-40. PubMed ID: 24881014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
    Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
    J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
    Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
    J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study.
    Colucci G; Ferguson J; Harkleroad C; Lee S; Romo D; Soviero S; Thompson J; Velez M; Wang A; Miyahara Y; Young S; Sarrazin C
    J Clin Microbiol; 2007 Nov; 45(11):3595-600. PubMed ID: 17898157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.